Author: Saravi, Seyed Soheil Saeedi; Beer, Jürg H.
Title: Apelin-potential therapy for COVID-19? Cord-id: xoaxpvg8 Document date: 2020_6_18
ID: xoaxpvg8
Snippet: We believe that, in parallel to the attempts for direct blockade of the SARS-CoV-2 penetration into host cell and repurposing drugs, finding new therapeutic strategies for patients with lung injury or cardiovascular complications/coagulopathies associated with COVID-19 should be paid particular attention. Apelin or its receptor agonists are of great potential treatment for COVID-19 through suppressing angiotensin-converting enzyme (ACE) and angiotensin II (Ang-II) production, as well as, down-re
Document: We believe that, in parallel to the attempts for direct blockade of the SARS-CoV-2 penetration into host cell and repurposing drugs, finding new therapeutic strategies for patients with lung injury or cardiovascular complications/coagulopathies associated with COVID-19 should be paid particular attention. Apelin or its receptor agonists are of great potential treatment for COVID-19 through suppressing angiotensin-converting enzyme (ACE) and angiotensin II (Ang-II) production, as well as, down-regulating angiotensin receptor 1 (AT1R) and ACE2 up-regulation. These drugs have potential to improve acute lung injury and cardiovascular/coagulopathy complications in COVID-19 which are associated with elevated Ang-II/Ang(1–7) ratio.
Search related documents:
Co phrase search for related documents- ace activity and acute lung: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- ace activity and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8
- ace activity and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- ace activity and lung tissue: 1, 2, 3, 4
- ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
- ace inhibitor and acute effect: 1
- ace inhibitor and acute lung: 1, 2, 3, 4, 5, 6
- ace inhibitor and acute lung injury: 1, 2, 3, 4
- ace inhibitor and lung injury: 1, 2, 3, 4
- ace inhibitor and lung tissue: 1, 2, 3, 4
- ace sequence similarity and acute lung: 1
- acute ards respiratory distress syndrome and adhesion molecule: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and lung fluid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and lung fluid accumulation: 1, 2
- acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute ards respiratory distress syndrome include and lung injury: 1, 2
- acute effect and adhesion molecule: 1, 2, 3
- acute effect and lung fluid: 1, 2
Co phrase search for related documents, hyperlinks ordered by date